Anna Runström

The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

Charlott Brunmark, Anna Runström, Lennart Ohlsson et al. · Journal of Neuroimmunology · 2002 · 165 citations

Immunogenetics, Autoimmune Disease, Immunology +8

Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders:  Structure−Activity Relationship

Stig Jönsson, Gunnar Andersson, Tomas Fex et al. · Journal of Medicinal Chemistry · 2004 · 156 citations

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity

Lena Winstedt, Sofia Järnum, Emma Andersson Nordahl et al. · PLoS ONE · 2015 · 114 citations · Full text

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

Stanley C. Jordan, Christophe Legendre, Niraj M. Desai et al. · Transplantation · 2020 · 106 citations · Full text

Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients

Christian Kjellman, Angela Q. Maldonado, Kristoffer Sjöholm et al. · American Journal of Transplantation · 2021 · 89 citations · Full text